The randomised induction for high-risk neuroblastoma comparing COJEC and N5-MSKCC regimens: Early results from the HR-NBL1.5/SIOPEN trial.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.10507
Abstract: 10507Background: From 2013-2017 the HRNBL1.5/SIOPEN trial tested the hypothesis that the N5-MSKCC induction regimen (Kushner, JCO 2004) increases metastatic complete response (mCR) or event-free su... read more here.
Keywords: trial; mskcc; siopen trial; randomised induction ... See more keywords